21 Nov 2026 14:25 14:50
COPD and bronchiectasis turn up together more often than chance would allow, and patients who have both do badly. In European and Indian cohorts the overlap carries about twice the mortality of either disease alone, along with more admissions and faster loss of lung function. The diagnosis is often made loosely; in the EMBARC registry, one in five patients labelled as COPD had no airflow obstruction. The ROSE criteria now give an objective definition and, importantly for us, accept biomass smoke as an exposure. Guidelines say little directly, so treatment is borrowed from both diseases. In India the overlap is commoner, often follows tuberculosis, and is still managed largely as COPD.